曲馬多引起胚胎發(fā)育缺陷的分子機制
[Abstract]:Drug abuse in maternal pregnancy is one of the most important factors for abortion. Tramadol is a widely used analgesic, which has the multiple effects of analgesia, appetite suppression and depression. Currently, the tendency of tramadol addiction and abuse is becoming more and more young. It is reported that more and more addicts are between 18-30 years of age and this age stage is positive. It is a woman's childbearing age. Clinical studies have shown that tramadol exposure during pregnancy greatly increases the abortion rate of women, but the specific mechanism is not clear. The relationship between craniofacial and neural crest development suggests that tramadol may interfere with the development of embryonic neural crest caused by embryonic defects. This topic further explores the effect of tramadol on the neural crest induction and migration, and studies the related molecular mechanisms. The results will be responsible for understanding the causes of the drug addiction and the causes of teratogenicity. It is of great practical significance and scientific value to evaluate the potential risk of this kind of drug in clinical application. Method first, the claw frog embryo in the cleavage stage was exposed to different concentrations of MBS culture containing tramadol (1:200,1:400,1:500). The whole process of embryo development was continuously observed under the Olympus anatomy microscope, and the embryo malformation was found. The drug concentration, and the experiment group and the control group of embryos were photographed under the stereoscopic microscope. The skull cartilage of the embryo (45 period) was stained with octyl blue, the development of the craniofacial cartilage was observed and photographed under the stereoscopic microscope. The objective evaluation of the effect of tramadol on the development of embryo was to find the drug concentration of the abnormal embryo. The concentration of tramadol in the embryo was measured by liquid chromatography and compared with the blood concentration of tramadol in human. The embryos were exposed to different concentrations of tramadol containing MBS culture. The embryos were cultured to the nerve plate period (14-15 phase) and the tail (25 phase). At this time the embryo had been induced and started to migrate, collect the embryo and construct the nerve. The related gene probes (Foxd3, N-tubulin, Sox2, Slug, Twist) induced by crest cells were used to detect the related transcriptional gene expression of Wnt, Fgf, BMP, and Notch/Delta in the embryonic neural plate and the tail teeth by in situ hybridization, and to investigate whether tramadol affects the neural crest induction and migration. In vitro experiments, U251 cells are used in the experiment. Transwell test was used to examine the effect of tramadol on cell migration in vitro and whether it was consistent with the response in the embryo. TUNEL was used to detect the apoptosis of fetal cells under tramadol exposure. The 17 stages of neural crest were stripped and Q-PCR was used to detect the expression of related adhesion molecules affecting the beginning of the migration of the neural crest. The difference between the control groups. Results (1) the early embryos were exposed to tramadol after exposure to abnormal cytochrome development, small embryo volume, small head and a series of developmental defects. (2) the development defects caused by tramadol exposure in early embryos were mainly caused by the inhibition of the migration of neural crest. (3) after tramadol exposure, cadherin adhered to adherence The confusion of molecular expression may be the cause of the disturbance of the neural crest migration. Conclusion the early embryo tramadol exposure is mainly caused by disturbance of the migration of the embryonic neural crest. The interference of tramadol on the neural crest development may be caused by the expression of the adhesion molecules interfering with the calcicin dependence. The clinical observation of tramadol Atopic dermatitis AD is one of the most common pruritus in Department of dermatology. The incidence of atopic dermatitis (atopic) is one of the most common pruritus in Department of dermatology. Its incidence is close to 20%. This disease is mainly pruritus. Clinical manifestations, easy to relapse, not easy to cure, patients often accompanied with anxiety, depression and other psychological disorders, negative emotions can cause neurotransmitter release, the impact of the HPA axis, and ultimately affect the phenotype of Th cells, the skin barrier function damage, itching tolerance, mental illness, worsening sleep disorders, the formation of a vicious cycle, clinical commonly used anti group Amines have only part of the clinical efficacy of AD in alleviating pruritus. Combined with our domestic and foreign research reports and our research basis, it is recognized that fluoxetine as a 5-HT reuptake inhibitor can relieve mental symptoms such as anxiety and depression. In addition, it can regulate the effects of lymphocyte proliferation on inflammatory dermatosis and can play a role in treating inflammatory dermatosis. We hope to provide a new idea and theoretical basis for the treatment of specific dermatitis by studying the therapeutic effect of fluoxetine on atopic dermatitis and the mechanism of action for the treatment of atopic dermatitis. Methods first, we use 2,4- two nitrochlorobenzene (DNCB) acetone (DNCB) acetone solution to stimulate BALB/c mice. A mouse model of allergic dermatitis was used to study the effect of 5-HT reuptake inhibitor on atopic dermatitis and the molecular mechanism of its effect. The clinical efficacy of 5-HT reuptake inhibitor (Fu Xiting) on the clinical efficacy, SCORAD score, depression and anxiety of the mice with atopic dermatitis was elucidated in detail by the 5-HT reuptake inhibitors. The role of inhibitors in the treatment of atopic dermatitis; by detecting the skin thickness and mast cell number of mice with HE staining and toluidine blue staining in mice, the changes in the RNA level of the total Ig E of the spleen, the cytokine (IL-2, IL-4, IL-13, IFN-r) m RNA levels were detected in the mice, and the molecular machine for the treatment of atopic dermatitis by 5-HT reuptake inhibitors was explored. Results (1) fluoxetine could reduce the clinical symptoms of AD mice. (2) fluoxetine could significantly improve the depression and anxiety of AD mice. (3) fluoxetine inhibited the inflammatory response of the tissue and reduced the number of mast cells in the dermis of AD mice. (4) fluoxetine lowered the level of Ig E in the serum of AD mice (5) fluoxetine could reduce the I in the spleen of AD mice. L-4/IL-13 cytokine levels significantly reverse the imbalance in the expression of Th1 and Th2 cell related factors. Conclusion fluoxetine can improve the pruritus of AD. Fluoxetine can improve the immune imbalance by reducing IL-4/IL-13 and inhibiting the production of mast cells. Fluoxetine may improve the anxiety by inhibiting psychological stress and depression and thus improve AD..
【學位授予單位】:重慶醫(yī)科大學
【學位級別】:博士
【學位授予年份】:2016
【分類號】:R714.2
【相似文獻】
相關期刊論文 前10條
1 蒙一純,PhilipBrauer;早期雞胚神經(jīng)管和微核神經(jīng)嵴的細胞凋亡[J];解剖科學進展;1997年03期
2 張建中;S—100蛋白在神經(jīng)嵴起源組織及其腫瘤中的分布[J];實用癌癥雜志;1988年02期
3 蔡良琬;神經(jīng)組織發(fā)育與再生的研究進展[J];基礎醫(yī)學與臨床;1994年06期
4 于蕾;倪潔麗;馬俊青;陳文靜;;Rap1b在斑馬魚神經(jīng)嵴中表達情況的初探[J];口腔生物醫(yī)學;2013年03期
5 Bahn CF ,王傳富;以神經(jīng)嵴起源為根據(jù)的角膜內皮疾病分類[J];眼科新進展;1986年02期
6 陸穎靜;陳樹寶;陸歐倫;;心臟神經(jīng)嵴受損與心臟畸形發(fā)生的關系[J];中華兒科雜志;1997年01期
7 劉積才;譚義書;;神經(jīng)嵴起源的少見腫瘤[J];腫瘤防治研究;1988年04期
8 張華;馮永;;PAX3基因對神經(jīng)嵴發(fā)育的調控及其在Waardenburg綜合征發(fā)病中的作用研究[J];聽力學及言語疾病雜志;2014年02期
9 趙曉晴;心臟神經(jīng)嵴發(fā)育與心臟錐干部畸形[J];國外醫(yī)學(兒科學分冊);2004年01期
10 劉向陽;王曄;宋維亞;張臻;;Wnt1-Cre標記心臟神經(jīng)嵴來源細胞在房室瓣分布的實驗研究[J];中華臨床醫(yī)師雜志(電子版);2012年22期
相關會議論文 前1條
1 藺海燕;劉芳;張傳森;張志英;孔征東;張喜;;移植了毛囊神經(jīng)嵴干細胞源性神經(jīng)元和施萬細胞的神經(jīng)移植體的體外特性[A];中國解剖學會2011年年會論文文摘匯編[C];2011年
相關博士學位論文 前3條
1 王曉鈺;高糖環(huán)境誘導的過度自噬抑制雞胚顱面部神經(jīng)嵴產(chǎn)生[D];暨南大學;2015年
2 李彥希;曲馬多引起胚胎發(fā)育缺陷的分子機制[D];重慶醫(yī)科大學;2016年
3 行勇軍;神經(jīng)嵴來源外胚間充質干細胞在牙向分化中的潛能及相關機制的研究[D];第三軍醫(yī)大學;2016年
,本文編號:2161430
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2161430.html